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Protocol for a systematic review of
quantitative burn wound microbiology in
the management of burns patients
Johnny Kwei1,2,3*, Fenella D. Halstead1,4, Janine Dretzke4,5, Beryl A. Oppenheim1,4 and Naiem S. Moiemen1,3,6
Abstract
Background: Sepsis from burn injuries can result from colonisation of burn wounds, especially in large surface area
burns. Reducing bacterial infection will reduce morbidity and mortality, and mortality for severe burns can be as
high as 15 %.
There are various quantitative and semi-quantitative techniques to monitor bacterial load on wounds.
In the UK, burn wounds are typically monitored for the presence or absence of bacteria through the collection and
culture of swabs, but no absolute count is obtained. Quantitative burn wound culture provides a measure of bacterial
count and is gaining increased popularity in some countries. It is however more resource intensive, and evidence for its
utility appears to be inconsistent.
This systematic review therefore aims to assess the evidence on the utility and reliability of different quantitative
microbiology techniques in terms of diagnosing or predicting clinical outcomes.
Methods/design: Standard systematic review methods aimed at minimising bias will be employed for study
identification, selection and data extraction. Bibliographic databases and ongoing trial registers will be searched and
conference abstracts screened. Studies will be eligible if they are prospective studies or systematic reviews of burn
patients (any age) for whom quantitative microbiology has been performed, whether it is compared to another
method. Quality assessment will be based on quality assessment tools for diagnostic and prognostic studies and
tailored to the review as necessary. Synthesis is likely to be primarily narrative, but meta-analysis may be considered
where clinical and methodological homogeneity exists.
Discussion: Given the increasing use of quantitative methods, this is a timely systematic review, which will attempt to
clarify the evidence base. As far as the authors are aware, it will be the first to address this topic.
Trial registration: PROSPERO, CRD42015023903
Keywords: Burns, Quantitative microscopy, Quantitative microbiology, Infection, Sepsis, Mortality, Systematic review
Background
Burn injuries are diverse but are unified in that they all
involve liquefactive necrosis of the largest organ in the
body, the skin. The skin is one of the most important
immune defence mechanisms that the human body has.
Consequently, infection is a significant problem in patients
who survive an initial burn injury. This complication
typically starts as bacterial colonisation and impacts sig-
nificantly on morbidity, mortality and healthcare costs.
Mortality for severe burns today stands at 5–15 % [1], with
the majority of the mortality due to pneumonia (25 %),
sepsis (26 %), urinary tract infections (22 %) and acute
burn wound infections (5 %) [2].
Although there are a variety of infection routes which
may lead to systemic infection and sepsis in the ther-
mally injured patient (such as wound, intravenous access
and chest infection), a key source of infection is the
breached area of the skin. Bacteria can be introduced
onto this surface in a number of different ways in the
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healthcare setting (via a number of exogenous and en-
dogenous sources), leading to colonisation. This typically
occurs in the form of a biofilm, a structured consortium
of microbial cells surrounded by a self-produced polymer
matrix. The longer the colonisation persists, the greater
the likelihood of systemic infection. Furthermore, the
greater the size of the breach, the greater the risks of bac-
terial invasion and systemic infection are thought to be.
Microbiological assessment can be with qualitative,
semi-quantitative or quantitative methods. Assessment
of burn wounds in the UK in general is qualitative and
semi-quantitative, utilising swab cultures.
Various authors [3, 4] have suggested that qualitative
and semi-quantitative methods should be replaced by fully
quantitative bacteriology in order to improve patient man-
agement. The use of burn wound biopsies for histological
(the staining and microscopic assessment of bacterial pres-
ence in different tissue planes) and quantitative (where an
absolute quantity of bacteria per unit of volume is mea-
sured) microbiological assessment of the burn wound orig-
inates from the findings of Teplitz et al. [5], who found
that in a rat model, increasing numbers of Pseudomonas
aeruginosa on a burn wound were followed by invasion of
the underlying viable tissue and clinical illness.
The clinical method for quantitative biopsy was de-
scribed by Loebl et al. [6]; however, various authors [7, 8]
since then have made modification to this method to bet-
ter fit the parameters defined in their studies. Conse-
quently, there now exist a variety of quantitative methods
leading to an absolute bacterial count but no universally
accepted ‘gold standard’. These methods differ in a num-
ber of ways, e.g. sample collection, method of biopsy and
timing of collection.
The evidence for the utility of quantitative burn wound
culture is inconsistent. Herruzo-Cabrera et al. [9] showed
that a semi-quantitative surface swab method distin-
guished between wound contamination and infection,
using a 105 CFU/g threshold as the definition of infection
by biopsy. This study was based on a porcine model where
greater than 105 surface bacterial counts were associated
with tissue infection. Furthermore, an association between
bacterial counts and wound healing has been suggested,
with Heggers et al. [10] finding that when bacterial counts
of 105 CFU/g of tissue exist, wound healing is slowed (in
an animal model) and Perry et al. [11] finding that skin
graft take is adversely affected by high counts.
In contrast, Steer et al. [7] investigated the relationship
between bacterial counts obtained by quantitative burn
wound biopsy culture and quantitative surface alginate
culture and clinical outcome following burn surgery and
found that in patients with burns >15 % total body surface
area (TBSA), a relationship between bacterial counts (ob-
tained by either method) and subsequent sepsis or graft
loss was not demonstrated.
The use of quantitative culture for the prediction of
clinical outcomes is only one possible prognostic vari-
able. Any evidence on the prognostic utility of bacterial
count (whether as a single prognostic factor or in con-
junction with others) needs to be evaluated in the con-
text of the evidence on the accuracy and reliability of the
counts obtained.
Given the increased use of quantitative methods in
some burns centres, and the varied and sometimes con-
flicting evidence base, a systematic review of all existing
evidence is warranted.
A scoping search was undertaken in MEDLINE,
PubMed and the Cochrane library to identify existing
(systematic) reviews and to gauge the volume of any pri-
mary studies on the topic. No existing systematic re-
views were identified, but there are a number of primary
studies, in addition to those mentioned above, exploring
different aspects of quantitative microbiology, for ex-
ample, related to measurement properties (e.g. inter-
rater reliability, measurement errors), correlation with
other culture methods or utility in predicting clinical
outcomes such as sepsis.
A well-conducted systematic review is thus warranted
in the use of quantitative microbiology in the manage-
ment of burns patients.
Methods/design
Definitions
To the best of our knowledge, no standard definitions
for qualitative or quantitative culture exist. For the pur-
pose of the systematic review, the following will be used
based on current literature [12]:
General methods
This protocol has been guided by the PRISMA-P check-
list [13]. The systematic review will be conducted using
standard systematic review methodology based on the
Cochrane handbook [14] and reported in accordance
with the Preferred Reporting items for Systematic Re-
views and Meta-Analyses (PRISMA) statement [13].
Search strategy
A number of bibliographic databases will be searched:
MEDLINE, Excerpta Medica Database (Embase), CINAHL,
the Cochrane Database of Systematic Reviews, PubMed
(the most recent 6 months), Cochrane Central Register of
Controlled Trials (CENTRAL) and Scopus.
Publicly available trial registers (such as ClinicalTrials.
Gov, UK Clinical Research Network Study Portfolio
Database (UKCRN), WHO International Clinical Trials
Registry Platform and the metaRegister of Controlled Tri-
als (mRCT)) will be searched for all trials and the ZETOC
database (British library) and Science Citation Index (Wed
of Science) searched for conference proceedings.
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In addition, abstracts from a number of national and
international burns and microbiology conferences will
be consulted from 2012 onwards in order to capture
studies that are not yet fully published (by reviewing all
posters and abstracts published in the meeting agenda).
These include ANZBA (Australian New Zealand Burns
Association), BBA (The British Burn Association), ABA
(American Burn Association), EBA (European Burn As-
sociation), ISBI (International Society for Burn Injuries),
EWMA (European Wound Management Association)
and ECCMID (European Congress of Clinical Microbiol-
ogy and Infectious Diseases). Citation checking of all
included studies will also be undertaken.
The search strategy will use a combination of text word
and MeSH terms relating to the population and the use of
quantitative burn wound microbiology. Given that the re-
search questions are broad, and aim to include any aspect
of quantitative microbiology in burns patients, there will
be no restriction by study design or outcomes.
There will be no restriction by publication date, lan-
guage or publication type (e.g. abstract or full publication).
A sample search strategy for MEDLINE is shown. This
will be adapted for use in other databases.
1. burn$.mp
2. exp burns/
3. “thermal injury”.mp
4. 1 or 2 or 3
5. biops$.mp
6. biopsy.mp
7. microscop*.mp
8. microscopy.mp
9. wound culture.mp
10. “quantitative adj3 culture”.mp
11. histology.mp
12. exp histology/
13. “bacterial count”.mp
14. swab$.mp
15. “microb* analy*”
16. “quantitative micro*”
17. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14
or 15 or 16
18. 4 and 17
Selection criteria
The selection criteria are outlined below. All human
studies relating to quantitative microbiology (biopsy cul-
ture and microscopy), and all possible clinical outcomes
for burn patients will be included.
Study design
The study design includes any prospective primary
studies (excluding single case reports), or systematic
reviews of such studies, assessing quantitative burn
wound microbiology either on its own or compared
to other methods.
Types of participants
The participants are patients of any age (paediatric and
adult) with burn injuries (of any size, mechanism or sur-
face) for whom wound quantitative microbiology has
been performed.
Setting
Studies in any setting will be included.
Intervention
This includes all methods of quantitative microbiology
applied to diagnosis of burn wounds. Quantification will
be as defined in Table 1.
Comparator
This includes either none or an alternative method (e.g.
semi-quantitative or qualitative) of obtaining a bacterial
count.
Outcomes
 Measurement properties of different quantitative
methods, e.g. in terms of reliability or repeatability
 Microbial load; quantitative (e.g. number of bacterial
colony-forming units per gram of tissue (cfu/g) or
per ml of liquid (cfu/ml)). Semi-quantitative studies
will be included when used as a comparator in a
study
 Diagnostic test accuracy measures (e.g. sensitivity or
specificity)
 Clinical outcomes (e.g. colonisation, infection,
antibiotic treatment, graft loss, bacteraemia, sepsis
and mortality) and tolerance/acceptability
 Measures relating to the relationship between
bacterial counts and clinical outcomes
 Resource related outcomes, e.g. length of hospital
stay and cost
Excluded
Qualitative microbiological culture
Semi-quantitative microbiological studies (unless used
as a comparator with quantitative study)
Animal studies
Case reports
Study selection
This will be a two-step process. Titles (and abstracts
where available) will initially be screened by two re-
viewers, using pre-specified screening criteria.
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Full texts of any potentially relevant articles will then be
obtained, and the two reviewers will independently apply
the full inclusion criteria. Any discrepancies between re-
viewers will be resolved by discussion or by referral to a
third reviewer. Appropriate portions of non-English lan-
guage articles will be translated where necessary and the
study selection process documented using a PRISMA flow
diagram [15]. Reference management software (Endnote)
will be used to record reviewer decisions, including rea-
sons for exclusion.
Data extraction
All data will be extracted by two reviewers independ-
ently using a standardised, piloted data extraction form.
Disagreements will be resolved through discussion or re-
ferral to third reviewer.
Data extraction will include (but not be limited to) the
following variables:
 Study design and aim (e.g. from observational,
prospective studies, randomised controlled trials and
systematic reviews)
 Patient characteristics (e.g. paediatric and adult
patients, severity of burn)
 Interventions given as part of standard care or for
prevention/treatment of infection (e.g. topical/
systemic antimicrobial regimens)
 Time and method of collection of the biopsy
 Method of quantitative microbiology (microscopy
and culture) and any alternatives (if used)
 Outcomes (e.g. sepsis, mortality, presence/absence
of infection, threshold of bacteria above or below
105 cfu/g)
 Statistical analysis model utilised
 Effect sizes and measures of uncertainty
 Length of follow-up
Where sufficient information on results cannot be ex-
tracted, study authors will be asked to supply necessary
information.
Quality assessment
Quality assessment of included studies will be under-
taken by two researchers independently, with any
discrepancies resolved through discussion or referral
to a third reviewer.
Items to be assessed will be based mainly on the Quality
Assessment in Diagnostic Accuracy Studies (QUADAS)-2
criteria [15] but tailored to the review topic where appro-
priate. Criteria will relate to, for example, whether different
methods for obtaining bacterial counts were performed
independently from one another and with no knowledge of
the results, whether all patients received/underwent testing
with both methods and whether pre-specified thresholds
were used for defining grade of infection.
It should be noted that quality assessment will be
complicated by the fact that there is no recognised refer-
ence test (gold standard) and that studies may use differ-
ent methods as their reference for defining levels of
infection. Additional criteria will relate to (i) the sam-
pling method, for example, whether the method for
obtaining a sample for culture was performed in the
same way for all patients and (ii) to the repeatability/reli-
ability of the different methods where studies assessed
this with duplicate samples or more than one assessor.
Where studies report a prognostic element (i.e. where a
bacterial count is linked to a later clinical outcome such
as sepsis), relevant items from the Quality in Prognosis
Studies (QUIPS) tool [16] will be used; these will in-
clude, for example, whether the outcome was clearly
pre-defined in advance and whether confounding factors
(such as antimicrobial treatment) were accounted for.
A sample of studies with different aims (e.g. looking at
reliability of a method, comparing two or more methods
or exploring a prognostic aspect) will be used to inform
the final checklist in order to ensure that it can be used
across different types of studies (providing they assess
quantitative culture); however, it is likely that not all ele-
ments will be relevant for all included studies. Quality
findings will be tabulated and synthesis will be narrative.
Analysis/synthesis
The main outcome measure of the included studies is
likely to be the absolute bacterial count per gram of tis-
sue, either as a continuous variable or a dichotomous
outcome (i.e. above or below one of more pre-defined
thresholds). Bacterial counts may be compared between
different methods, for example, with a correlation coeffi-
cient presented to show the strength of the relationship
or a percentage above and below a certain threshold pre-
sented for different methods (or for duplicate samples).
Studies may also present a positive or negative predictive
value, i.e. chance of a person with a positive (negative)
result obtained with one method actually having (not
having) an infection (with the definition of infection
based on another method). Sensitivities and specificities
may also be presented, but interpretation is likely to be
hampered by the lack of a validated reference standard.
Table 1 Definitions of qualitative, semi-quantitative and
quantitative culture for wound swabs and biopsies
Swab or biopsy
Qualitative Presence or absence of growth
Semi-quantitative Grading of the bacterial presence as either/or ±
(scanty), + (few), ++ (moderate) and +++ (numerous)
or as categories (e.g. <105 CFU/g)
Quantitative Where an absolute quantity is provided (following
e.g. Miles and Misra quantification [22])
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Where studies have assessed the utility of bacterial
counts in the prognosis of clinical outcomes (e.g. sepsis
or graft loss), odd ratios or relative risks may be pre-
sented or calculable from raw data (i.e. patients above/
below a certain threshold with/without the relevant clin-
ical outcome).
Synthesis will most likely be narrative, with results for
the same outcome metrics (e.g. correlation coefficient,
percentage agreement and positive predictive value) tab-
ulated and the direction of effect described, in the con-
text of any clinical and methodological heterogeneity.
Heterogeneity is likely to be substantial, in the form of
different methods for obtaining bacterial counts, differ-
ent approaches to sampling (e.g. anatomical site, timing,
number of samples), different laboratory approaches to
culturing and different patient characteristics (e.g. sever-
ity of burn, co-morbidities). This will likely preclude
meta-analysis, particularly for diagnostic test accuracy
outcomes given the lack of a recognised reference test;
formal evaluation of publication bias through funnel
plots will therefore also not be possible. Visual presenta-
tion of results in forest or other plots without pooling
may be explored should there be sufficient studies
reporting the same outcome metric.
Potential sub-groups of interest may be based on stud-
ies using different quantitative microbiology methods,
different semi-quantitative comparators, and different
outcomes or with differences in patients’ antimicrobial
therapy. The possibility of presenting findings for differ-
ent sub-groups of studies will be explored; however, the
anticipated scarcity of the overall evidence and the likely
substantial heterogeneity may preclude this. For the
same reasons, sensitivity analysis based on quality as-
sessment is also unlikely to be feasible. However, the
methodological quality of studies will be taken into ac-
count when drawing conclusions from findings.
Discussion
Given the high mortality resulting from severe burn
wound infection and sepsis, prevention of infection and/
or early diagnosis of infection or sepsis are of utmost
importance for patient care. In the UK, assessment of
burn wounds is typically performed through the collec-
tion of charcoal swabs from the burnt surface, followed
by standard culture on solid agar plates. This method re-
sults in a species identification and is either qualitative
(presence or absence of bacteria is measured) or semi-
quantitative (presence of bacteria is graded from scanty
to heavy growth based on growth on a streaked agar
plate) and is used to guide the duration of topical anti-
microbial therapy.
This method is however limited in that it is difficult to
differentiate between surface colonisation and deeper
infection and, furthermore, provides little indication of
the absolute number of bacteria present.
Since the advent of burn wound quantitative biopsy,
there has been numerous studies evaluating its use,
both in terms of its ability to reliably determine infec-
tion and to predict future adverse clinical outcomes
(like graft loss or sepsis). As far as the authors are
aware, there are no existing systematic reviews on
this topic and the evidence from the modest volume
of primary studies appears conflicting. There are also
cost implications associated with quantitative micro-
biology, as this technique is more resource intensive
than qualitative or semi-quantitative methods.
Various studies showed inconclusive efficacy. Loebl et al.
[6] in 1974 introduced the use of quantitative micro-
biology in the assessment of burn wound patients
and demonstrated that 88 % of paediatric and 45 %
of adult burns patients with positive biopsies (>104
organisms per gram of biopsy) developed clinical
signs of sepsis and was a good predictor of burns
sepsis. This predictive result of quantitative biopsy
for sepsis was further supported by Buchanan et al.
[17] in 1986.
However, McManus et al. [18] and Steer et al. [7], in
the following decade, provided evidence that the positive
results of quantitative biopsy did not correlate with
depth of bacterial wound tissue invasion and sepsis. In
fact, there is a suggestion that bacterial density from
quantitative biopsies of the same wound at different sites
varies significantly.
Globally, a large number of burn centres advocate and
use a variety of microbiological methods (e.g. wound
biopsy, swab cultures, capillary gauze, moist swab,
absorbent disc, rapid slide and frozen section techniques)
to quantify the bacterial bio-burden of a burn
wound. Quantitative culture of a burn wound biopsy
provides a measure of the bacterial count (in terms
of colony-forming units (CFU)) per gram of tissue
and is deemed to be superior than the non-quantitative
methods, based on the presumption that there is a
direct relationship between the bio-burden load on
the surface to the risk of invasion, deeper infection,
bacteraemia and sepsis and that certain thresholds of
bacterial count can predict these possible clinical
outcomes. 105 CFU/g is commonly used as the
threshold for distinguishing between colonisation and
infection [3–5, 10, 11].
Quantitative cultures of wound biopsies are regularly
used in the USA (in 47 % of centres) and Europe (in 27 %
of centres) for diagnosis of burn wound infection;
however, ≤5 % of burns centres [7] in the UK use this
method. There is significant resources and time allocated
to performing wound biopsies and cultures, as compared
to standard wound swab and cultures.
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Already, burn injuries pose a large financial strain, with
healthcare costs in Australia ranging from AU$71,056 [19]
(approximately £35,700) for a non-severe burns patient, to
an average of greater than AU$500,000 [20] (approxi-
mately £251,000) for a severely burnt patient. Costs are
similar in the USA, where the average cost for looking
after a major burn patient is estimated to be US$200,000
(approximately £128,000), and more than US$18 billion is
spent on specialised burn care annually [21]. No accurate
financial data for the UK was identified, but costs are
likely to be similarly high.
Despite this, quantitative microbiology is being in-
creasingly used globally, particularly in the USA, and
there is a growing interest in the UK as to whether this
technique should be used more widely in order to pro-
vide the best possible care to burns patients.
The overall volume of evidence however is thought to
be relatively sparse (<50 studies), and evidence for the
practice is unclear. The proposed systematic review
therefore aims to review all evidence relating to any as-
pect of quantitative culture and to highlight any gaps in
the evidence base.
There is anticipated heterogeneity in the results of this
systematic review. Preliminary search also showed vari-
ability in study design, with the use of quantitative
microbiology in comparison to histology, bacteraemia,
sepsis and mortality in an inconsistent manner.
Specifically, any evidence relating to the following
questions will be reviewed:
i) Measurement properties of quantitative burn wound
biopsy culture (with histological microscopy),
in terms of internal consistency, reliability and
measurement error
ii) Measurement properties of quantitative burn
wound biopsy culture (with histological microscopy)
compared to other methods of quantification (swab
culture or other methods)
iii)Correlation between bacterial wound density and
colonisation, bacterial invasion and/or systemic
infection (e.g. bacteraemia and sepsis)
iv) Correlation between bacterial wound counts and
likelihood of progression to bacteraemia and sepsis
(i.e. prognostic value of bacterial counts obtained by
quantitative microbiology)
v) Any models evaluating multiple prognostic factors
(including bacterial counts obtained by quantitative
microbiology) in terms of progression to bacterial
invasion, bacteraemia or sepsis.
Diagnostic accuracy is unlikely to have been evalu-
ated in the absence of a gold standard for obtaining a
bacterial count; however, studies measuring this will
also be included.
A systematic review, which synthesises all the available
evidence, is therefore urgently required. An evaluation
of the utility of the bacterial count for predicting clinical
outcomes may be hampered by a lack of evidence (and
vast heterogeneity) on the validity of any one method for
obtaining a count; however, any gaps in the evidence
and/or uncertainties around findings will be highlighted.
An overall appraisal of the study methodology and risk
of bias of all included studies will help to make an as-
sessment of the robustness of findings and may also help
to inform the study design of any future research.
In order to provide the best standard of care for pa-
tients in the UK and justify the cost effectiveness of
quantitative microbiology, a well-conducted systematic
review will define the deficiencies in evidence-based
practice and will hopefully be identified as a recommen-
dation for clinical practice in the current treatment of
burn patients.
If areas of deficiency in evidence for practice are
identified, this may instigate future research in these
areas of quantitative microbiology.
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